Advances in the treatment of immune checkpoint inhibitors for esophageal cancer / 中国医师杂志
Journal of Chinese Physician
;
(12): 142-145, 2022.
Artículo
en Chino
| WPRIM
| ID: wpr-932034
ABSTRACT
As a new therapeutic strategy for esophageal cancer, immunotherapy has attracted more and more attention. The completed and ongoing clinical trials of immunotherapy for esophageal cancer confirm the great potential of immune checkpoint inhibitors in esophageal cancer. Future research will focus on the combination of immunotherapy with existing or new therapeutic modalities and the identification of populations likely to benefit from immunotherapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Chinese Physician
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS